synthase kinase-3 (GSK-3) Radiosynthesis Positron emission tomography (PET) Cancer Alzheimer's disease a b s t r a c t SB-216763 is a novel, potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor with an IC 50 value of 34 nM. , a new potential PET agent for imaging of GSK-3, was first de
Synthesis and evaluation of [11C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β)
✍ Scribed by Cole, Erin L.; Shao, Xia; Sherman, Phillip; Quesada, Carole; Fawaz, Maria V.; Desmond, Timothy J.; Scott, Peter J.H.
- Book ID
- 122229588
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 683 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0969-8051
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract 2β‐Carbomethoxy‐3β‐(4‐fluorophenyl)‐[N‐^11^C‐methyl]tropane, a potent inhibitor of dopamine transport, was prepared by N‐methylation of the appropriate nor‐methyl precursor in DMF with [^11^C]iodomethane. After derivatization of unreacted precursor with a long chain acyl halide, the rad
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v